- Study Says Most Parents Don’t Use Car Seats In Ride Share Vehicles Like Uber
- This 12-Year-Old Boy Is A Sophomore Aerospace Engineering Major!
- Fire Safety Experts Warn Of Hand Sanitizer Danger After A Mom and Kids Escape House Fire
- Recall Alert: Peaches May Be The Cause Of Salmonella Outbreak, 68 People Ill
- Summer Vacation In The Days Of COVID: Tips To Stay Safe
- How To Safely Grocery Shop During The Coronavirus Pandemic
- Michigan Teen With Vape-Related Illness Undergoes Double Lung Transplant
- Teen Kicks Off Anti-Vaping Campaign From Hospital Bed
- Teenager Receives Life Sentence For Strangling Sister To Death Over A Wi-Fi Password
- Toddler Falls To Death From 11th Deck of Cruise Ship
600,000 GlaxoSmithKline Inhalers Recalled
A recall has been announced for inhalers produced by GlaxoSmithKline, LLC (GSK). Approximately 600,000 inhalers are being recalled due to a defective delivery system.
A FDA report said that some inhalers were “out of specification results for leak rate“.The recall was classified as a Class II recall which means that “the products might cause a temporary health problem, or pose only a slight threat of a serious nature,” according to the FDA.
The affected inhalers were made in a plant in Zebulon, North Carolina. The recall is reported to be voluntary and was initiated by GSK.Full Product Details:
Full Product Details:
Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 metered inhalations, net weight 18 g inhalers, RX only.
You can read more on this recall, by clicking here.
0 comments